Sudden unexplained death in psychiatric in-patients

British Journal of Psychiatry

Volumn 176, Issue MAY, 2000, Pages 405-406

  Appleby, Louis ^a   Thomas, Simon ^b   Ferrier, Nicol ^c   Lewis, Glyn ^d   Shaw, Jenny ^a   Amos, Tim ^a  

^a WITHINGTON HOSPITAL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c ROYAL VICTORIA INFIRMARY   (United Kingdom)

^d UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; LITHIUM DERIVATIVE; NEUROLEPTIC AGENT; THIORIDAZINE; TRICYCLIC ANTIDEPRESSANT AGENT;

EDITORIAL; HEART ARRHYTHMIA; HUMAN; LONG QT SYNDROME; MENTAL PATIENT; PSYCHIATRIC TREATMENT; RISK FACTOR; SUDDEN DEATH; TORSADE DES POINTES;

ANTIPSYCHOTIC AGENTS; DEATH, SUDDEN; DEATH, SUDDEN, CARDIAC; ENGLAND; HEART CONDUCTION SYSTEM; HUMANS; INPATIENTS; RESEARCH DESIGN; RISK FACTORS; WALES;

EID: 0034021698     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.176.5.405     Document Type: Editorial

References (23)

1. Alvarez-Mena, S. & Frank, M. (1973) Phenothiazine-induced T-wave abnormalities. Effects of overnight fasting. Journal of the American Medical Association, 224, 730-733.
2. Appleby, L., Shaw, J. & Amos, T. (1997) National Confidential Inquiry into Suicide and Homicide by People with Mental Illness. British Journal of Psychiatry, 170, 101 102.
3. _, _, _, et al (1999) Suicide within 12 months of contact with mental health services: national clinical survey. British Medical Journal, 318, 1235-1239.
4. Arita, M. & Surawicz, B. (1973) Electrophysiologic effects of phenolhiazines on canine cardiac fibers. Journal of Pharmacology and Experimental Therapeutics, 184, 619-630.
5. Axelsson, R. & Aspenstrom, G. (1982) Electrocardiographs changes and serum concentrations in thioridazine-treated patients. Journal of Clinical Psychiatry, 43, 332-335.
6. Ban, T. A. & St-Jean, A. (1965) Electrocardiographir changes induced by phenothiazine drugs. American Heart Journal, 70, 575-576.
7. Baxter, D. N. (1996) The mortality experience of individuals in the Salford psychiatric case register. I. All-cause mortality. British Journal of Psychiatry, 168, 772-779.
8. Buckley, N. A., Whyte, I. M. & Dawson, A. H. (1995) Cardiotoxicity more common in thioridazine overdose than other neuroleptics. Journal of Toxicology Clinical Toxicology, 33, 199-201.
9. Committee on Safety of Medicines (1999) Suspension of availability of sertindole (Serdolect) due to reports of sudden cardiac death. Current Problems in Pharmacovigilance, 25, 1.
10. Harris, E. C. & Barraclough, B. (1998) Excess mortality of mental disorder. British Journal of Psychiatry, 173, 11-53.
11. Hartigan-Go, K., Bateman, D. N., Nyberg, G., et al (1996) Concentration-related pharmacodynamic effects of thioridazine and its metabolites in man. Clinical Pharmacology and Therapeutic, 60, 543-553.
12. Heiman, E. M. (1977) Cardiac toxicity with thioridazine-tricyclic antidepressant combination. Journal of Nervous and Mental Disease, 165, 139-143
13. Hansen, V., Arnesen, E. & Jacobsen, B. K. (1997) Total mortality in people admitted to a psychiatric hospital. British Journal of Psychiatry, 170, 186-190.
14. Mehtonen, O. P., Aranko, K., Malkonen, L., et al (1991) Survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in Finland. Acta Psychiatrica Scandinavica, 84, 58-64.
15. Minardo, J. D., Heger, J. J., Miles, W. M., et al (1988) Clinical characteristics of patients with ventricular fibrillation during anti-arrhythmic drug therapy. New England Journal of Medicine, 319, 257-262.
16. Nguyen, P.T., Scheinmann, M. M. & Seger, J. (1986) Polymorphous VT: clinical characterisation, therapy and the QT interval. Circulation, 74, 340-349.
17. Pratt, C. M., Eaton, C., Francis, M., et al (1989) The inverse relationship between baseline left ventricular ejection fraction and outcome of anti-arrhythmic therapy: a dangerous imbalance in the risk - benefit ratio. American Heart Journal, 118, 433-440.
18. Reilly, J. G., Ayis, S., Ferrier, I. N., et al (2000) Q1c interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet, in press.
19. Royal College of Psychiatrists (1997) The Association Between Antipsychotic Drugs and Sudden Death Report of the Working Group of the Royal College of Psychiatrists' Psychopharmacology Sub-Group. Council Report CR57. London: Royal College of Psychiatrists.
20. Ruschena, D., Mullen, P. E., Burgess, P., et al (1998) Sudden death in psychiatric patients. British Journal of Psychiatry, 172, 331-336.
21. Sims, A. C. P. & Prior, M. P. (1980) Arteriosclerosis-related deaths in severe neurosis. Comprehensive Psychiatry, 23, 181-185.
22. Slater, W., Lamport, S., Podrid, P.T., et al (1988) Clinical predictors of arrhythmic worsening by anti arrhythmic drugs. American Journal of Cardiology, 61, 349.
23. Thomas, S. H. L. (1994) Drugs, QT interval abnormalities and ventricular arrhythmias. Adverse Drug Reactions and Toxicological Reviews, 13, 77-102.